Interlaboratory differences between the literatures used for Vmax and intrinsic clearance data for kcat and CLint,u calculations, including concentrations of UDPGA, alamethicin, MgCl2, and % of BSA
Literature | UDPGA (mM)a | Alamethicinb | MgCl2 (mM)b | BSA (%)c | Bufferd |
---|---|---|---|---|---|
(Achour et al., 2018) | 5 | 10μg/ml | 5 | — | 100mM Tris-HCl, pH 7.5 |
(Al-Jahdari et al., 2006) | 3 | 50μg/ml | 8 | — | 50mM Tris-HCl, pH 7.6 |
(Benoit-Biancamano et al., 2009) | 2 | — | 10 | — | 50mM Tris-HCl, pH 7.7 |
(Bhatt et al., 2019) | 2.5 | 100μg/ml | — | 0.01 | 100mM phosphate, pH 7.4 |
(Chen et al., 2018) | — | 25mg/ml | 5 | — | 50mM Tris-HCl, pH 7.4 |
(Cubitt et al., 2009) | 5 | 50μg/ml | 10 | — | 100mM phosphate, pH 7.1 |
(Gill et al., 2012) | 5 | 50μg/mg protein | 3.45 | 1 to 2e | 100mM phosphate, pH 7.1 |
(Gill et al., 2013) | 5 | 50μg/ml | 3.45 | — | 100mM phosphate, pH 7.1 |
(Knights et al., 2016) | 5 | 50μg/mg protein | 4 | — | 100mM phosphate, pH 7.4 |
(Komura and Iwaki, 2011) | 2 | 50μg/mg protein | 10 | — | 100mM Tris-HCl, pH 7.4 |
(Liang et al., 2011) | 5 | 25μg/ml | 5 | — | 50mM Tris-HCl, pH 7.4 |
(Miles et al., 2005) | 3 | 50μg/mg protein | 10 | — | 75mM Tris-HCl, pH 7.45 |
(Picard et al., 2005) | 2 | — | 10 | — | 100mM Tris-HCl, pH 7.4 |
(Rowland et al., 2008) | 5 | 50μg/mg protein | 4 | — | 100mM phosphate, pH 7.4 |
(Scotcher et al., 2017) | 5 | 50μg/mg protein | 3.45 | 1 | 100mM phosphate, pH 7.4 |
(Shimizu et al., 2007) | 3 | 50μg/ml | 10 | — | 50mM Tris-HCl, pH 7.4 |
(Soars et al., 2001) | 5 | — | 10 | — | 100mM Tris-maleate, pH 7.4 |
(Soars et al., 2003) | 5 | 50μg/ml | 1 | — | 100mM phosphate, pH 7.1 |
(Walsky et al., 2012) | 5 | 10μg/ml | 5 | — | 100mM Tris-HCl, pH 7.5 |
aMinimum 5mM required for reliable glucuronidation activities for kcat and CLint,u calculations (Miners et al., 2021).
bFactors influencing measured Vmax specifically (Miners et al., 2021).
cReduces substrate Km, impacting on measured CLint,u (Miners et al., 2021).
dIncreases glucuronidation activities, reflected as greater mean CLint,u (Badée et al., 2019).
eUGT1A1, 2% BSA; UGT1A3, 1% BSA.
—, No data.